论文部分内容阅读
一、引言前列腺是男子的主要附性腺,其机能是分泌精浆,它的机能有赖于男性激素睾酮的刺激。早在1786年已经知道去势能导致前列腺萎缩。1865年前列腺癌在临床确诊。1941年Huggins和Hodges采用去势和雌激素治疗前列腺癌症,40多年来一直沿用至今。前列腺良性增生是从前列腺的输尿管周区(头部)发展起来的,一般为腺细胞及肌纤维基质组成的混合体。相反,前列腺癌是起自前列腺外周部份(尾部)的腺癌。这两种类型病理性增生常发生于男性老年人。
First, the introduction Prostate is the main male gonads, its function is to secrete seminal plasma, its function depends on the stimulation of male hormone testosterone. As early as 1786, it was known that castration can lead to prostate atrophy. Prostate cancer in 1865 clinically diagnosed. Huggins and Hodges in 1941 the use of castrate and estrogen in the treatment of prostate cancer, has been in use for more than 40 years. Prostate benign prostatic hyperplasia is from the prostate of the ureter (head) development, usually a mixture of glandular cells and muscle fiber matrix. In contrast, prostate cancer is adenocarcinoma originating from the periphery of the prostate (caudal). These two types of pathological hyperplasia often occur in the elderly male.